Follow The Filings

DXCM DexCom

Health Care, filed as DEXCOM INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Sold by 1 manager in 2026 Q2

  • 3 Owners
  • Max 1.1%
  • $29M
  • 1 exit 1 small

In 2026 Q2 First Eagle Investment Management sold out of DexCom.

Who owns this now

Largest portfolio weights among holders, up to 1.1% (Nathan Fischel, Dafna Capital Management). Not free-float ownership.

  1. Nathan Fischel 1.1%
  2. David Witzke 1.1%
  3. Ron Baron Add 0.02%

Who owns DXCM

Sorted by value, long equity only, as of 2026 Q2.

History
Ron Baron, Bamco Inc. (Baron Capital) 0.02% Small add +1.7% 245,000 $17M History
David Witzke, Avidity Partners Management 1.1% Hold 100,000 $6.7M History
Nathan Fischel, Dafna Capital Management 1.1% Hold 86,279 $5.8M History
First Eagle Investment Management exited 2026 Q2 Last 2026 Q1 <0.01% Exit 0.00% 58 $4K History

3 current, 1 exited last period, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by DXCM's executives, directors and 10% owners in the last 12 months, from their Form 4s

All DXCM insider trades
  • $1M bought by 1 insider
  • None no sales outside a trading plan
  • $13M sold by 9 insiders under 10b5-1 plans
  1. Sadie Stern EVP Chief People & Culture Off
    Planned sale
    $202K 2,565 shares at $78.62 2.1% of stake
    Traded Oct 27 Filed Oct 28
    ↗
  2. Michael Jon Brown EVP Chief Legal Compliance Off
    Planned sale
    $145K 1,700 shares at $85.48 1.7% of stake
    Traded Oct 15 Filed Oct 19
    ↗
  3. Sadie Stern EVP Chief People & Culture Off
    Planned sale
    $221K 2,565 shares at $86.15 2% of stake
    Traded Sep 28 Filed Sep 30
    ↗
  4. Nicholas Augustinos Director
    Planned sale
    $680K 8,089 shares at $84.04 22% of stake
    Traded Sep 14–15 Filed Sep 16
    ↗
  5. Michael Jon Brown EVP Chief Legal Compliance Off
    Planned sale
    $143K 1,700 shares at $84.04 1.7% of stake
    Traded Sep 15 Filed Sep 16
    ↗
  6. Jereme M Sylvain EVP, Chief Financal Officer
    Planned sale
    $303K 3,638 shares at $83.27 2.4% of stake
    Traded Sep 10 Filed Sep 14
    ↗
  7. Sadie Stern EVP Chief People & Culture Off
    Planned sale
    $227K 2,565 shares at $88.37 2% of stake
    Traded Aug 27 Filed Aug 28
    ↗
  8. Kevin R Sayer Chair
    Planned sale
    $2.4M 26,756 shares at $90.01 8.1% of stake
    Traded Aug 20 Filed Aug 24
    ↗
  9. Michael Jon Brown EVP Chief Legal Compliance Off
    Planned sale
    $156K 1,700 shares at $91.93 1.6% of stake
    Traded Aug 14 Filed Aug 17
    ↗
  10. Bridgette P Heller Director
    Planned sale
    $89K 1,012 shares at $88.29 3.3% of stake
    Traded Aug 12 Filed Aug 13
    ↗
  11. Mark G Foletta Director
    Planned sale
    $331K 4,000 shares at $82.66 7.6% of stake
    Traded Jul 31–Aug 3 Filed Aug 4
    ↗
  12. Kevin R Sayer Chair
    Planned sale
    $2M 26,756 shares at $76.32 7.5% of stake
    Traded Jul 20 Filed Jul 21
    ↗
  13. Michael Jon Brown EVP Chief Legal Compliance Off
    Planned sale
    $127K 1,700 shares at $74.42 1.6% of stake
    Traded Jul 15 Filed Jul 16
    ↗
  14. Kevin R Sayer Chair
    Planned sale
    $1.9M 26,756 shares at $72.00 7% of stake
    Traded Jul 6 Filed Jul 7
    ↗
  15. Michael Jon Brown EVP Chief Legal Compliance Off
    Planned sale
    $128K 1,700 shares at $75.55 1.6% of stake
    Traded Jun 15 Filed Jun 17
    ↗

Also filed in the last 12 months, not counted as buying or selling: 23 stock grants, 19 share withholdings for taxes, and 9 gifts.

Congress

5 members of Congress traded DXCM in the last three years: 4 buys and 6 sales. 2 members listed it in 2025 annual reports.

All Congress trades
  1. Tina Smith D-MNSpouse Sell $100K–$250K May 7 filed May 10
  2. Tina Smith D-MNSpouse Partial sale $100K–$250K Apr 29 filed May 10
  3. John Boozman R-ARJoint Buy $1K–$15K Jan 26 filed Feb 15
  4. Jefferson Shreve R-IN-6 Sell $15K–$50K May 12, 2025 filed Jun 22, 2025
  5. Jefferson Shreve R-IN-6 Buy $15K–$50K May 8, 2025 filed Jun 22, 2025
  6. Robert P. Bresnahan, Jr. R-PA-8 Buy $1K–$15K May 15, 2025 filed Jun 9, 2025

SEC filings

Recent issuer filings from EDGAR, 7 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,8.01,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc

Source: SEC EDGAR submissions, updated about 16 hours ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $3.62B $4.03B $4.66B
Gross profit $2.29B $2.44B $2.8B
Gross margin * 63.2% 60.5% 60.1%
Net income $541.5M $576.2M $836.3M
Net margin * 14.9% 14.3% 17.9%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $4.43B $4.3B $4.03B
Total non-current assets * $1.84B $2.18B $2.31B
Total assets $6.26B $6.48B $6.34B
Total current liabilities $1.56B $2.93B $2.14B
Total non-current liabilities * $2.64B $1.45B $1.45B
Total equity $2.07B $2.1B $2.75B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $0.748B $0.99B $1.44B
Cash from investing -$507.2M -$207.5M $536M
Cash from financing -$0.319B -$0.735B -$1.69B
Net change in cash -$75.8M $39.8M $311.8M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.